Olivier S Descamps
Olivier S Descamps publishes mostly in Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine, on topics such as Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins and Cholesterol and Lipid Metabolism.
- World rank
- #178,551 of 7,710,434 ranked researchers
- Rank in Belgium
- #1,278 of 67,186
- Works
- 172
- Citations
- 17k
- Citations per work
- 100.1
What does Olivier S Descamps research?
Olivier S Descamps's work is mostly in Medicine (55%), Biochemistry, Genetics and Molecular Biology (4%), Economics, Econometrics and Finance (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences9454.6%
- Medicine9454.6%
- Everything else6437.4%
- Life Sciences74.2%
- Social Sciences73.8%
- 1Surgery30% of their works
- 2Endocrinology, Diabetes and Metabolism11% of their works
- 3Cardiology and Cardiovascular Medicine8% of their works
- 4Physiology5% of their works
- 5Cancer Research4% of their works
- 6Economics and Econometrics4% of their works
Research topics
- Lipoproteins and Cardiovascular Health
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Cholesterol and Lipid Metabolism
- Cancer, Lipids, and Metabolism
- Alzheimer's disease research and treatments
- Lipid metabolism and disorders
- Cholinesterase and Neurodegenerative Diseases
- Health Systems, Economic Evaluations, Quality of Life
Which keywords describe Olivier S Descamps's research?
The keywords of their largest research topics: Statins, Cardiovascular Disease Prevention, Cholesterol-lowering, Cholesterol, Atherosclerosis, Metabolic Syndrome, Cardiovascular Disease and Diabetes.
- Quality of Life
- Cholinesterase Inhibitors
- Lipoprotein Lipase
- Tau Pathology
- Lipid Metabolism
- Metabolism
- Diabetes
- Metabolic Syndrome
- Cholesterol
- Cardiovascular Disease Prevention
- Statins
- Cholesterol-lowering
- Atherosclerosis
- Cardiovascular Disease
- LXR
- Fatty Acid Synthase
- Amyloid Hypothesis
- ANGPTL3
- Acetylcholinesterase
- Cost-effectiveness Analysis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Statins1192 topics
- Cardiovascular Disease Prevention1011 topic
- Cholesterol-lowering1011 topic
- Cholesterol883 topics
- Atherosclerosis813 topics
- Metabolic Syndrome532 topics
- Cardiovascular Disease421 topic
- Diabetes421 topic
- LXR281 topic
- Metabolism281 topic
- Fatty Acid Synthase181 topic
- Lipid Metabolism181 topic
- Amyloid Hypothesis131 topic
- Tau Pathology131 topic
- ANGPTL3111 topic
- Lipoprotein Lipase111 topic
- Acetylcholinesterase101 topic
- Cholinesterase Inhibitors101 topic
- Cost-effectiveness Analysis101 topic
- Quality of Life101 topic
Where does Olivier S Descamps work?
Olivier S Descamps's main affiliation in the publication record is Hôpital de Jolimont, Belgium.
How many publications and citations does Olivier S Descamps have?
OpenAlex counts 172 works and 17,217 citations for Olivier S Descamps, an h-index of 48, ranking #178,551 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Olivier S Descamps. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.